Results 301 to 310 of about 1,381,466 (410)

A cross-sectional study on the prevalence of different types of anemias in pregnant women in a rural tertiary care center.

Ms. Harika Peethambaram, Hiranmaye Mokhasunavisu, Ramya Sindhura Tammireddi, Dr.Anusha Kollapu, Lekha Rani, Bhagyalakshmi Atla   +5 more
openalex   +2 more sources

Maternal underweight and child growth and development - Authors' reply.

, 2013
Cnattingius, Jenny A Cresswell, Kristensen, Lawn, Mary J De Silva, Oona MR Campbell, Sebire, Tennant, Véronique Filippi   +8 more
core   +1 more source

Population Pharmacokinetics and Exposure–Response Analyses of Momelotinib, Its Active Metabolite (M21), and Total Active Moiety in Myelofibrosis

Clinical Pharmacology &Therapeutics, EarlyView.
Momelotinib, a Janus kinase (JAK) 1/JAK2/activin A receptor type 1 inhibitor, is approved for the treatment of myelofibrosis with anemia. These analyses characterized the population pharmacokinetics of momelotinib and its active metabolite M21 following administration of the commercial tablet formulation in patients with myelofibrosis from phase II/III
Benjamin Rich, Meenakshi Srinivasan, Yu Liu Ho, Sandra A.G. Visser, Geraldine Ferron‐Brady, Georgios Vlasakakis   +5 more
wiley   +1 more source

Factors affecting anemia prevention behaviors among pregnant women in Phetchabun Province, Northern Thailand. [PDF]

BMC Pregnancy Childbirth
Khuanloy P, Songthap A, Mekrungrongwong S.   +2 more
europepmc   +1 more source

Real‐World Edoxaban Concentrations in Older Patients Receiving Reduced‐Dose Regimens

Clinical Pharmacology &Therapeutics, EarlyView.
Real‐world edoxaban concentrations in older patients receiving reduced‐dose regimens. Low trough concentrations (< 12 ng/mL) were associated with an increased risk of thromboembolism. Among patients meeting the ELDERCARE‐AF criteria, low drug levels were more frequent with the 15 mg regimen than with the 30 mg regimen.
Sung‐Chun Tang, Shin‐Yi Lin, Chih‐Hao Chen, Yen‐Bin Liu, Li‐Ting Ho, Ching‐Hua Kuo, Yu‐Fong Peng, Chih‐Fen Huang, Jiann‐Shing Jeng   +8 more
wiley   +1 more source

Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma

Clinical Pharmacology &Therapeutics, EarlyView.
Extended interval dosing regimens of immune checkpoint inhibitors have been implemented widely. However, their approval was mainly based on pharmacokinetic modeling and simulations. Consequently, comparative safety data of extended interval dosing regimens in a real‐world setting are limited.
Ruben Malmberg, Maaike M. Hofman, Fatima Ashad, Alaa Daloul, Stefani Oosterveld, Edwin A. Basak, Esther Oomen‐de Hoop, Astrid A. M. van der Veldt, Arjen Joosse, Roelof W. F. van Leeuwen, Ron H. J. Mathijssen   +10 more
wiley   +1 more source

The effect of late-gestational anemia on maternal and neonatal outcomes in twin pregnancies: a retrospective cohort study. [PDF]

Ann Med
Li X, Huang Y, Chen J, Cao X, Zhang Y, Li Y, Wang K, Zhao F, Ren S, Wang S, Qu P.   +10 more
europepmc   +1 more source

Monocyte maturation pattern by flow cytometry expression of CD64, CD300e, and CD14 correlates to presence of myeloid neoplasm and helps identify blast equivalents in the setting of monocytic neoplasm

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract CD300e is a marker of mature monocytes in flow cytometry; however, there is limited detailed information on staining patterns in conjunction with other monocyte markers. We evaluated the flow cytometric staining patterns of CD64, CD14, and CD300e in 12 negative and 33 positive peripheral blood specimens and 16 negative and 56 positive bone ...
Jenny Zhang, Jacob Kaplan, Elizabeth Courville   +2 more
wiley   +1 more source

Emerging biomarkers for early detection of aplastic anemia in HIV: A narrative review. [PDF]

Medicine (Baltimore)
Obeagu EI, Obeagu GU.
europepmc   +1 more source

Validation of a candidate international harmonisation protocol‐compliant measurement procedure for reticulocyte counting using an erythrocyte gating strategy excluding the platelet component

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract The International Harmonisation Protocol (IHP) for Reticulocyte Percentage (%Retic) in CLSI‐H44‐A2 is a microscopic procedure performed on a new‐methylene‐blue‐stained blood film (NMB‐IHP). However, IHP‐compliant Measurement Procedures (MPs) based on flow cytometry (FCM) are recommended for practical and accurately assigned reference values ...
Yutaka Nagai, Tomohiro Takeda, Hiromichi Matsushita, Tomoko Arai, Yoko Yatabe, Hiromitsu Yokota, Takayuki Mitsuhashi, Masatoshi Wakui, Yohko Kawai, Hiroshi Kondo   +9 more
wiley   +1 more source